A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial.
暂无分享，去创建一个
I. Seong | J. Chae | Seung‐Jung Park | S. Yun | Young-Hak Kim | J. Ko | M. Hong | Duk‐Woo Park | Cheol-Whan Lee | Seung‐Whan Lee | Seong-Wook Park | Jae‐Hwan Lee | Jae‐Hyeong Park | N. Lee | Y. Cho | J. Kim | K. Chun | Si-Wan Choi | Hyun-Sook Kim | K. Rhee | J. Jeong
[1] I. Seong,et al. A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus. , 2008, Journal of the American College of Cardiology.
[2] I. Liu,et al. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. , 2008, Journal of the American College of Cardiology.
[3] F. Eberli,et al. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. , 2008, European heart journal.
[4] M. Pfisterer,et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. , 2007, Journal of the American College of Cardiology.
[5] Simon Wandel,et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis , 2007, The Lancet.
[6] P. Serruys,et al. The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. , 2006, European heart journal.